iminvestor101, it looks like you have accepted that there is no PBT2, as Stamler does not talk about it, in spite, I am sure you have not forgotten PBT2. O.K., PBT2 also need human studies but they are done in a fraction of 2 years required for ATH434. IMO, PBT2 will be accepted before ATH434. When the otitis media study by Dr. Neville starts ( IMO, there will be many different types of them), there will be a lot of positive activity on the market.
Ann: Alterity Launches ATH434 Phase 2 Clinical Trial, page-11
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $18.65K | 5.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 57052005 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 125915200 | 27 |
View Market Depth
| Last trade - 14.28pm 29/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |